Triazole agonists of the apj receptor

Disclosed are compounds of formula (i) and formula (ii), pharmaceutically acceptable salts thereof, stereoisomers of any of the above, or mixtures thereof, which are apj receptor agonists and are useful in the treatment of cardiovascular disease and other disorders. The compounds of formula (i) and of formula (ii) have the following structures: in these structures, the definitions of the variables are found in the description.